Genotipia

Genotipia company information, Employees & Contact Information

Explore related pages

Related company profiles:

Lideramos la formación y divulgación en genética médica y genómica en el mundo hispanohablante. En Genotipia conectamos ciencia, formación y actualidad para transformar el conocimiento genético en salud y progreso. Desde hace más de 10 años, somos el punto de encuentro para médicos, facultativos, profesionales sanitarios, investigadores, estudiantes y organizaciones que apuestan por el potencial de la genética para mejorar la vida de las personas. 🎓 Formación online especializada, con programas universitarios y cursos de formación continuada y más de 190 docentes expertos en sus respectivas áreas. 🧬 Actualidad científica de referencia, con más de 2.500 artículos y noticias publicadas. 🌎 Comunidad global, con más de 8.000 alumnos y +250.000 miembros en la comunidad. Ofrecemos contenidos rigurosos, actualizados y accesibles desde cualquier lugar. Ya seas un profesional en busca de actualización, una institución educativa o una empresa del sector, en Genotipia encontrarás un aliado estratégico para crecer en genética y genómica. Síguenos, fórmate y colabora con nosotros. Porque el futuro de la medicina empieza con el conocimiento genético.

Company Details

Employees
16
Founded
-
Address
Biohub Vlc, Valencia,valencia 46024,spain
Industry
Technical And Vocational Training
NAICS
Technical and Trade Schools
Apprenticeship Training
Other Technical and Trade Schools
HQ
Valencia, Valencia
Looking for a particular Genotipia employee's phone or email?

Genotipia Questions

News

Will Medigene AG (MDG1) stock hit Wall Street targets - 2025 Trading Recap & Daily Growth Stock Tips - newser.com

Will Medigene AG (MDG1) stock hit Wall Street targets - 2025 Trading Recap & Daily Growth Stock Tips newser.com

Is Medigene AG (MDG1) stock a top pick for value investors - July 2025 Weekly Recap & Reliable Price Action Trade Plans - Trung tâm Dự báo KTTV quốc gia

Is Medigene AG (MDG1) stock a top pick for value investors - July 2025 Weekly Recap & Reliable Price Action Trade Plans Trung tâm Dự báo KTTV quốc gia

Medigene and EpimAb to co-develop T cell engagers - Pharmaceutical Technology

Medigene and EpimAb to co-develop T cell engagers Pharmaceutical Technology

Medigene and EpimAb Biotherapeutics Enter into a Co-Development Partnership for TCR-Guided T Cell Engagers - GlobeNewswire

Medigene and EpimAb Biotherapeutics Enter into a Co-Development Partnership for TCR-Guided T Cell Engagers GlobeNewswire

Cash-strapped Medigene lays off 40% of staff, pauses plan to enter clinic - Fierce Biotech

Cash-strapped Medigene lays off 40% of staff, pauses plan to enter clinic Fierce Biotech

Medigene and Epimab to codevelop TCR-guided T-cell engagers - BioWorld MedTech

Medigene and Epimab to codevelop TCR-guided T-cell engagers BioWorld MedTech

Levels Update: What market sentiment indicators show for Medigene AG (MDG1) stock - 2025 Buyback Activity & Fast Moving Stock Trade Plans - Trung tâm Dự báo KTTV quốc gia

Levels Update: What market sentiment indicators show for Medigene AG (MDG1) stock - 2025 Buyback Activity & Fast Moving Stock Trade Plans Trung tâm Dự báo KTTV quốc gia

Medigene Presents Latest Data on UniTope and TraCR Technology at PEGS and SITC 2024 - Oncodaily

Medigene Presents Latest Data on UniTope and TraCR Technology at PEGS and SITC 2024 Oncodaily

Layoff tracker: BMS, Alector and Medigene part ways with staff - PharmaLive

Layoff tracker: BMS, Alector and Medigene part ways with staff PharmaLive

German Biotech Expands Oncology Deal with Bluebird bio to $1.5Bn - Labiotech.eu

German Biotech Expands Oncology Deal with Bluebird bio to $1.5Bn Labiotech.eu

AGC partners with Medigene - BioProcess Insider - BioProcess International

AGC partners with Medigene - BioProcess Insider BioProcess International

Roivant’s Latest “Vant” Launches $1B+ TCR Immunotherapy Partnership with Medigene - Genetic Engineering and Biotechnology News

Roivant’s Latest “Vant” Launches $1B+ TCR Immunotherapy Partnership with Medigene Genetic Engineering and Biotechnology News

Amgen Acquires MediGene AG Spinoff Catherex for $10.5 Million Upfront - BioSpace

Amgen Acquires MediGene AG Spinoff Catherex for $10.5 Million Upfront BioSpace

Roivant forms Asian cell therapy ‘vant’, with Medigene’s help - PMLiVE

Roivant forms Asian cell therapy ‘vant’, with Medigene’s help PMLiVE

Medigene's Global Research and Collaboration Agreement with BioNTech to Extend Beyond Initially Announced Term - Oncodaily

Medigene's Global Research and Collaboration Agreement with BioNTech to Extend Beyond Initially Announced Term Oncodaily

Medigene's Phase 1/2 Trial Testing MDG1011 in Myeloma, Others to Begin - Rare Cancer News

Medigene's Phase 1/2 Trial Testing MDG1011 in Myeloma, Others to Begin Rare Cancer News

Medigene, QLT say Eligard dosage wins EU approval - Reuters

Medigene, QLT say Eligard dosage wins EU approval Reuters

Germany Sanctions MediGene’s Topical Treatment for Genital Warts - Genetic Engineering and Biotechnology News

Germany Sanctions MediGene’s Topical Treatment for Genital Warts Genetic Engineering and Biotechnology News

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant